“The benefits of our managed service contract were clearly demonstrated during the recent merger of microbiology, virology and immunology services into a single blood sciences group within the Trust. Our Abbott facilities manager was instrumental in this, co-ordinating the transfer of equipment so that it did not interrupt services or have an impact on patients. The Abbott team also helped us to develop more efficient combined workflows, listening to our needs and delivering solutions that matched our requirements. For example, we are now running syphilis assays on our ARCHITECT systems, meaning all antenatal samples can be run on a single analyser, and we can also run a high performance HIV test on this platform.”
Rebecca Stalham, Marketing and Contracts Director at Abbott, added: “A managed service contract provides trusts with a cost-effective, guaranteed service, allowing laboratory staff to focus on high value work which ultimately leads to better patient care, and we are happy that this model is working so well for Imperial College Healthcare.”
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs approximately 91,000 people and markets its products in more than 130 countries.
Abbott has been operating in the UK for 75 years and currently has operations in Maidenhead, Berkshire (UK Headquarters)
Abbott's media alerts and other information are available on the company’s website at www.abbott.co.uk (https://smtp.kdm-